Lianluo Smart Ltd (LLIT) stock is lower by 8.06% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With LLIT Stock Today?
Lianluo Smart Ltd (LLIT) stock has fallen -2.54% while the S&P 500 is unchanged 0% as of 2:52 PM on Tuesday, Jul 28. LLIT is lower by -$0.01 from the previous closing price of $0.59 on volume of 374,361 shares. Over the past year the S&P 500 has risen 7.23% while LLIT is lower by -43.56%. LLIT lost -$0.25 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Lianluo Smart Ltd click here.
More About Lianluo Smart Ltd
Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.
